Inspira Technologies achieves all key objectives in high-level government talks

Inspira achieved all key strategic objectives in its high-level talks with a government health authority, located outside of the United States, on July 8, a meeting previously announced by the Company on July 7, establishing a definitive pathway for the nationwide adoption of the Company’s ART100 system and creating the foundation for a future global scale-up. This breakthrough follows a direct invitation from the government, which recognizes the ART100 as a clinically validated, field-proven system, driving the decision to initiate a national integration process. The newly established pathway defines a strategic framework designed to accelerate the integration of the ART100 into the country’s national emergency infrastructure. Furthermore, it creates the foundation for a global distribution and manufacturing hub, a structure intended to significantly enhance the value and accelerate the execution of the Company’s existing $22.5M purchase order, as announced on July 2, 2025.